Patient Guide: Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 33 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04721015
Status: ACTIVE_NOT_RECRUITING
Condition: Carcinoma, Non-Small-Cell Lung
Phase: PHASE1

Find a Study Location Near You

This study is available at 33 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Boston, Massachusetts
  • St. Louis, Missouri
  • Huntersville, North Carolina
  • • And 30 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily